Recently, Lv et al. [115] showed that the overexpression of HDAC1 decreased cisplatin sensitivity, promoted proliferation and blocked the suppressive effects of miR-34a on cell proliferation in ovarian cancer cells. This evidence concerns the gene HDAC1 and ovarian cancer.